BI
PFE icon

Binnacle Investments’s Pfizer PFE Stock Holding History

Binnacle Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$201K Buy
7,876
+2,124
+37% +$52.4K 0.12% 73
2025
Q2 		$139K Buy
5,752
+2,267
+65% +$52.9K 0.09% 83
2025
Q1 		$88.3K Buy
+3,485
New +$91.2K 0.06% 102

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Binnacle Investments's PFE Position: Q3 2025 in Review

Binnacle Investments increased its Pfizer (PFE) stake by 37% in Q3 2025, buying an estimated $52.4K and bringing the position to 7,876 shares worth $201K. The position accounts for 0.12% of the portfolio, ranked #73.

Binnacle Investments first reported a position in PFE in Q1 2025 and has held it in 3 quarters since. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Binnacle Investments held 7,876 shares of Pfizer worth $201K as of Q3 2025.
  • Binnacle Investments bought 2,124 Pfizer shares in Q3 2025, an estimated $52.4K.
  • Pfizer made up 0.12% of Binnacle Investments's portfolio in Q3 2025, its #73 holding.
  • Binnacle Investments first reported a position in Pfizer in Q1 2025 and has held it in 3 quarters since.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.